Investor Overview

NASDAQ: XBIT0.4912.90Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
08/22/16XBiotech Announces Grand Opening Date for New Commercial Manufacturing FacilityPrinter Friendly Version
08/10/16XBiotech to Provide Second Quarter 2016 Business Update on August 16Printer Friendly Version
07/22/16XBiotech Provides Update on Xilonix™ Phase III Programs in US and EUPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »